Antibodies to low density lipoprotein receptor-related protein 4 in seronegative myasthenia gravis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2017
   Review
2. Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.PloS one · 2015
   Article
3. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.Journal of anatomy · 2014
   Review

Corrections and comments

• Comment on
  Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.2012

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as